Contracts › HT942524C0030
HT942524C0030: Medical Research and Development Contract Dha Sbir Sequential Phase Ii, Proposal No. H2S-0060, Titled: "Enhanced Rapid Assay for Monitoring Immunosuppressant Drugs in Whole Blood."
Awarded to Intelligent Optical Systems, Inc. by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
24 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942524C0030 |
|---|---|
| Awardee | Intelligent Optical Systems, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 25 March 2024 to 24 July 2027 |
| Potential end | 24 July 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record